CONTALDI, ELENA
 Distribuzione geografica
Continente #
EU - Europa 273
NA - Nord America 165
AS - Asia 55
Totale 493
Nazione #
US - Stati Uniti d'America 164
IE - Irlanda 122
SE - Svezia 57
IT - Italia 41
HK - Hong Kong 28
SG - Singapore 24
FR - Francia 18
DE - Germania 15
CZ - Repubblica Ceca 13
UA - Ucraina 3
IR - Iran 2
BE - Belgio 1
CA - Canada 1
FI - Finlandia 1
KR - Corea 1
NL - Olanda 1
RO - Romania 1
Totale 493
Città #
Dublin 120
Hong Kong 28
Boardman 22
Strasbourg 16
Singapore 14
Brno 13
Chandler 11
Milan 11
Lawrence 10
Princeton 10
Mülheim 7
San Mateo 7
Turin 6
Wilmington 5
Alessandria 4
Ashburn 3
Jacksonville 3
Monmouth Junction 3
Novara 3
Seattle 3
Bremen 2
Cologne 2
Frankfurt am Main 2
Menlo Park 2
Vigevano 2
Alba 1
Amsterdam 1
Ann Arbor 1
Bari 1
Bosco Chiesanuova 1
Brussels 1
Cambridge 1
Corte Madera 1
Erding 1
Helsinki 1
Monza 1
Munich 1
Oleggio 1
Omaha 1
Oradea 1
Reggio Emilia 1
Rho 1
Rome 1
Seoul 1
Seveso 1
Toronto 1
Tronzano Vercellese 1
Zanjan 1
Totale 332
Nome #
Relationship between circulating CD4+ T lymphocytes and cognitive impairment in patients with Parkinson's disease 41
The prevention of falls in patients with Parkinson's disease with in-home monitoring using a wearable system: a pilot study protocol 36
Polymorphisms of dopamine receptor genes and parkinson’s disease: Clinical relevance and future perspectives 36
Immune Response Modifications in the Genetic Forms of Parkinson’s Disease: What Do We Know? 36
The Role of Tau beyond Alzheimer’s Disease: A Narrative Review 36
Telehealth in neurodegenerative diseases: Opportunities and challenges for patients and physicians 32
Potential protective role of ACE-inhibitors and AT1 receptor blockers against levodopa-induced dyskinesias: A retrospective case-control study 31
The Immune System as a Therapeutic Target for Old and New Drugs in Parkinson's Disease 31
The impact of SNCA variations and its product alpha-synuclein on non-motor features of parkinson’s disease 30
Motor and non-motor symptom improvement after mRNA-1273 vaccine in a Parkinson’s disease patient 28
T Lymphocytes in Parkinson's Disease 22
A very early onset of juvenile parkinsonism 21
Striatal dopamine transporter imaging in Parkinson's disease drug-naïve patients: focus on sexual dysfunction 20
Relationship between [123I]FP-CIT SPECT data and peripheral CD4 + T cell profile in newly-diagnosed drug-naïve Parkinson's disease patients 18
Expression of Transcription Factors in CD4 + T Cells as Potential Biomarkers of Motor Complications in Parkinson's Disease 18
Levodopa Equivalent Dose of Safinamide: A Multicenter, Longitudinal, Case–Control Study 16
Lymphocyte Count and Neutrophil-to-Lymphocyte Ratio Are Associated with Mild Cognitive Impairment in Parkinson's Disease: A Single-Center Longitudinal Study 15
A case of early-onset Parkinson's disease in a patient with KBG syndrome 10
The role of peripheral immunity in Parkinson's Disease 8
Menstrual-Related Fluctuations in a Juvenile-Onset Parkinson's Disease Patient Treated with STN-DBS: Correlation with Local Field Potentials 8
Disease mechanisms as subtypes: Immune dysfunction in Parkinson's disease 8
The PROB-PD trial: a pilot, randomised, placebo-controlled study protocol to evaluate the feasibility and potential efficacy of probiotics in modulating peripheral immunity in subjects with Parkinson’s disease 7
Parkinson's disease and chronic inflammatory demyelinating polyneuropathy: Broadening the clinical spectrum of VCP mutations 6
Parkinsonism in SCA19/22: Dopamine Transporter Imaging in an Italian Family Harboring a Novel Mutation 6
Totale 520
Categoria #
all - tutte 3.909
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.909


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202113 0 0 0 0 1 1 2 2 4 0 3 0
2021/202280 3 8 10 12 2 0 0 3 10 1 5 26
2022/2023245 10 19 10 4 6 16 14 8 118 1 29 10
2023/2024175 16 5 12 5 21 2 29 3 6 0 23 53
2024/20257 7 0 0 0 0 0 0 0 0 0 0 0
Totale 520